• USP Dietary Supplement Standards & Verification Programs – Making Quality Visible 2023.08.31 (16:20 – 16:50) United States Pharmacopeia (USP) Seong Jae (SJ) Yoo, Senior Manager Detail View
  • Clostridium butyricum K-Butyric acid bacteria 2023.09.01 (10:20 – 10:50) NPK Co., Ltd JO GYUNG HYUN, Principal Research Engineer Detail View
  • Liposomal Botanicals and Nutraceuticals 2023.09.01 (11:00 – 11:30) Botanic Healthcare Pvt Ltd., INDIA Dr. H N Shivaprasad, Director-Global Business Detail View
  • Vitamin K2-7 - A Multi-tasking Vitamin 2023.09.01 (11:40 – 12:10) EverSpring Co., ltd. M.Sc. Mikkel Jungersen, Advisor to Everspring Detail View
  • Various effects of mass-produced rare ginsenoside Compound K, and its usage as a functional ingredient for natural medicine and health foods 2023.09.01 (13:00 – 13:30) AceEMzyme Wan-Taek Im, CEO Detail View
  • Case Announcement of Implementation of the Nagoya Protocol and Access and Benefit-Sharing on genetic resources 2023.09.01 (13:40 - 15:30) National Institute of Biological Resources Detail View
  • Implementation of the Nagoya Protocol(and ABS) and ESG Compliance 2023.09.01 (13:40 - 15:30) Lee & KO Team leader of ESG Team Detail View
  • Nagoya Protocol compliance case: Hanmi Pharmaceutical Group 2023.09.01 (13:40 - 15:30) Hanmi Pharmaceutical Jisun Nam, Head of Legal Department, Attorney at law Detail View